Peter B. Jensen
Horsholm, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Characterization of resistance to a recombinant hexameric Fas-ligand (APO010) in human cancer cell lines.
Journal: Experimental hematology
Published: August 28, 2019
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.
Journal: Breast cancer (Tokyo, Japan)
Published: July 18, 2019
A drug response predictor to guide treatment for breast cancer.
Journal: Pharmacogenomics
Published: April 16, 2019
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.
Journal: Breast cancer research and treatment
Published: April 29, 2018
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
Journal: PloS one
Published: January 02, 2018
Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.
Journal: PloS one
Published: November 24, 2016
Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer.
Journal: PloS one
Published: October 08, 2015
Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.
Journal: Journal of medicinal chemistry
Published: October 30, 2013
Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET.
Journal: PloS one
Published: June 24, 2013
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice.
Journal: BMC cancer
Published: September 05, 2012
Last Updated: 09/26/2026